Frank M. Sands, 10% Owner at Inhibikase Therapeutics, Inc. (IKT), bought 4,137,930 shares at $1.45 ($6.0M) on 2025-11-21, disclosed to the SEC on 2025-11-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.45 | 2,068,965 | $3.0M | 50.0% |
| 2 | $1.45 | 2,068,965 | $3.0M | 50.0% |
| Total | $1.45 avg | 4,137,930 | $6.0M | 100% |